论文部分内容阅读
采用体外反博（ECP）治疗10例阿尔茨海默型老年痴呆（SDAT）患者，从临床症状、仪器检查及血和脑脊侵液（CSF）中生物活性物质的改变等评价了ECP对SDAT的治疗作用。主要结果：体外反对8周后，SDAT患者的脑SPECT显像显示普遍性脑供血增加；血液超氧化物歧化酶（SOD）活力和强啡肽A1－13含量明显升高；CSF中生长抑素含量、SOD活力等明显增加；而脯氨酸和蛋氨酸浓度均明显下降。上述结果表明，体外反搏对SDAT确有积极的治疗作用．
Ten patients with Alzheimer-type senile dementia (SDAT) were treated with in vitro anti-BoP (ECP) and ECP was evaluated against SDAT from clinical symptoms, instrumental tests, and changes in bioactive substances in blood and cerebrospinal fluid (CSF). Therapeutic effect. MAIN OUTCOMES: After 8 weeks of in vitro challenge, brain SPECT imaging in SDAT patients showed an increase in universal cerebral blood supply; blood superoxide dismutase (SOD) activity and dynorphin A1-13 content increased significantly; somatostatin in CSF The content, SOD activity, etc. increased significantly, while the concentrations of valine and methionine decreased significantly. The above results show that the external counterpulsation does have a positive therapeutic effect on SDAT.